Managing COVID-19 alone can be a difficult in many cases, but for persons with pre-existing conditions such as diabetes the challenge can be all the greater, and specific considerations need to be taken when prescribing treatment to manage them. This book is a culmination of scientific work driven by personal conviction to enhance the care provided to the vulnerable populations COVID-19 patients with diabetes. It spans topics from the epidemiology and predictors of complications and increased mortality in COVID-19, to in-depth discussion of the pathophysiology of the disease. Pathophysiology of COVID-19 is addressed comprehensively as common soil pathogenetic pathways, and by organ system such as the lung, the kidney and most pertinently for diabetes, the diabetic foot ulcers and diabetes co-morbidities. A multi-disciplinary approach was needed to manage these complex patients; thus, the authors represent a variety of disciplines including pharmacology, endocrinology, nephrology, infectious diseases, podiatry, vascular surgery, pulmonary/critical care, and general medicine. Written by experts in the field, Diabetes and COVID-19: Considerations and Clinical Management is a blueprint for treatment of patients with both conditions.

COVID-19 pandemic caused by SARS-COV-2 virus has evolved into a global crisis and is a major concern especially for the diabetes community. People with diabetes mellitus have increased morbidity and mortality associated with COVID-19 infection. Conversely, COVID-19 infection and treatment may predispose to hyperglycemia. Potentially modifiable risk factors have been discussed and urgent need to mitigate the risks is warranted. In this book chapter we summarize the available evidence on COVID-19 and type 2 diabetes mellitus including link between COVID-19 and type 2 diabetes, pathophysiology, clinical manifestations, management and complications.

Since the end of 2019, Coronavirus disease 2019 (COVID-19), which caused more than 6 million deaths worldwide, immediately gained attention as a major public health issue. The clinical spectrum of COVID-19 encompasses a wide range of conditions, from a minor upper respiratory tract infection to severe interstitial pneumonia with respiratory and even multi-organ failure and a high in-hospital mortality. This unpredictability encouraged the development of tailored vaccination tactics to control the viral propagation and slow the progression of the disease. During the pandemic, a vast amount of clinical and laboratory data was gathered, allowing researchers to learn more about the progression of the disease as well as the efficacy and safety of the anti-SARS-Cov-2 vaccine.

"The world has not been the same after the Covid–19 pandemic. The virus brought social and cultural change and became the root cause of resetting global operations and basic human functioning. The prolonged symptoms of Covid–19 include fatigue, headaches, flu, and chronic pain in vital organs. Moreover, many people have reportedly been diagnosed with Post Covid–19 diabetes type 1 or type 2 related to pancreatic injury under the Covid infection. Dr. Frank's book Post Covid–19 long–hauler risk of diabetes type 1 or type 2 provides detailed procedural methods deployed to tackle the spread of the progression of disease and monitor the stages and progress of its treatment. Dr. Frank aims to assist physicians and caretakers in examining the severity of injury to the pancreas and derive a standard action plan to salvage healthy cells that will stop the progression of the disease from damaging the remaining healthy BETA cells. The book contains multiple sections covering medications, food management, exercise, and an overview of a proposed design powered mobile application to collect and store screening data. Dr. Frank Hamo is a Ph.D. degree holder in biomedical engineering and strives to put his vast knowledge to enhance the efficiency of healthcare institutions. By bringing in the resources of biomedical technology, Dr. Frank's vision remains to improve the dynamics of the overall treatment." For more information visit: https://covid19complication.com/

The coronavirus disease 2019 (COVID-19) outbreak has spread throughout the globe and much time has passed since it was declared as a pandemic by the World Health Organization (WHO). COVID-19: Diagnosis and Management provides clinicians and scholars all the information on this disease in 2 volumes. Readers will find a concise and visual reference for this viral disease and will be equipped with the knowledge to assess and manage Sar-Cov-2 infection cases in clinical settings. This book is divided into two parts (I and II). Part I provides comprehensive information about 1) History of Coronaviruses, 2) Epidemiology of COVID-19, 3) Clinical presentation of this viral disease and 4) COVID-19 diagnosis. Part II covers broader topics about this communicable disease including 1) the prevention and treatment methodology, 2) mortality and long-term complications, 3) COVID-19 vaccines and future perspectives. Key Features: Covers all the aspects of COVID-19 making this a perfect textbook for virology and medical students. Chapter wise description and segregation of topics from pathophysiology to diagnosis and management of COVID-19. Six chapters in the first part which focus on clinical basics of COVID-19. Six chapters in the second part which cover broader topics for practical infection control. Multiple tables and figures which summarize and highlight important points. Presents a summary of the current standards for the evaluation and diagnosis of COVID-19. Features a detailed list of references, abbreviations, and symbols. This book is an essential textbook reference for medical students, scientists (virologists, pulmonologists) and public health officials who are required to understand COVDI-19 diagnosis and management as part of their clinical training or professional work.